Table 6.
Program |
Test type | Screening interval years or times in LT |
Age eligible national population |
|||
Type | Status | Age (yr) | Persons (× 1000) | |||
Austria | NonPB | Natw | FOBT | 1 or 2 | > 50 | 2210 |
NonPB | Natw | CS | 10 | > 50 | 2210 | |
Belgium | No Prog | 2880 | ||||
Bulgaria | NonPB | Natw | FOBT | 1 | > 31 | 2340 |
Cyprus | PB | Natw-plan | FOBT | 1 in LT | 50 | 10 |
PB | Natw-plan | CS | 1 in LT | 55 | 10 | |
Czech Republic | NonPB | Natw | FOBT | 2 | > 50 | 3010 |
Denmark | No Prog | 1540 | ||||
Estonia | No Prog | 370 | ||||
Finland | PB | Natw-roll ong | FOBT | 2 | 60-69 | 570 |
France | PB | Natw-roll ong | FOBT | 2 | 50-74 | 16 600 |
Germany | NonPB | Natw | FOBT | 1 and 2 | > 50 | 24 500 |
NonPB | Natw | CS | 10 (2 in LT) | 55-74 | 18 800 | |
Greece | NonPB | Natw | FOBT | 5 | > 50 | 3180 |
NonPB | Natw | CS | 5 | > 50 | 3180 | |
Hungary | PB | Natw-pilot | FOBT | 2 | 50-70 | 2630 |
Ireland | No Prog | 940 | ||||
Italy | PB | Natw-roll ong | FOBT | 2 | 50-69 (70-75) | 13 800 |
PB | Reg-roll ong | FS | 1 in LT | 58 or 60 | 80 | |
Latvia | NonPB | Natw | FOBT | 1 | > 50 | 630 |
Lithuania | No Prog | 870 | ||||
Luxembourg | No Prog | 120 | ||||
Malta | No Prog | 120 | ||||
Netherlands | No Prog | 4460 | ||||
Poland | PB | Natw-roll ong | CS | 10 | 50-65 | 7500 |
Portugal | PB | Natw-plan | FOBT | 2 | 50-70 | 2520 |
Romania | PB | Natw-plan | FOBT | 2 | 50-74 | 5800 |
Slovak Republic | NonPB | Natw | FOBT | > 50 | 1360 | |
NonPB | Natw-plan | CS | 10 | > 50 | 1360 | |
Slovenia | PB | Natw-plan | FOBT | 2 | 50-69 | 490 |
Spain | PB | Reg-pilot | FOBT | 2 | 50-69 | 210 |
Sweden | PB | Reg-plan | FOBT | 2 | 60-69 | 220 |
UK | PB | Natw-roll ong | FOBT | 2 | (50) 60-69 (74) | 7600 |
Dual prog/test | -25 630 | |||||
Subtotal | 106 490 | |||||
Excluded pop. | 29 500 | |||||
Total | 135 990 |
PB: Population based; Prog: Program; Natw: Nationwide; Reg: Regional; Plan: Planning; Roll ong: Rollout ongoing; Pilot: Piloting; CS: Colonoscopy; LT: Lifetime. dual prog/test: Individuals entered twice due to screening programs of different implementation or using different screening tests. excluded pop.: Individuals excluded from national target populations due to regional or national variations in the age group targeted for screening, or due to lack of screening programs in some regions of countries with regional implementation status. Adapted from: von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening - First Report. ISBN 978-92-79-08934-3. European Communities (publ.) Printed in Luxembourg by the services of the European Commission, 2008. Available from: URL: http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_screening.pdf. Last accessed on August 4, 2009.